Articles From: Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference to Saratoga Investment Corp. to Report Fiscal Fourth Quarter and Year End 2014 Financial Results and Hold Conference Call


RICHMOND, Calif.
Sign-up for Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences investment picks
2014/5/20
SAN JOSE, Calif.
Sign-up for Sanmina Corporation Announces Pricing Of Senior Secured Notes Offering investment picks
2014/5/20
SAN JOSE, Calif.
Sign-up for Sanmina Corporation Announces Proposed Offering Of Senior Secured Notes investment picks
2014/5/20
SAN JOSE, Calif.
Sign-up for Sanmina Corporation Announces Tender Offer And Consent Solicitation investment picks
2014/4/22
SAN JOSE, Calif.
Sign-up for Sanmina Reports Second Quarter Fiscal 2014 Results investment picks
2014/4/25
PARIS, April 25, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced on World Malaria Day that 300 million treatments of anti-malarial ASAQ Winthrop ® have been delivered in Africa since the medication became available in 2007.
Sign-up for SANOFI : Sanofi Reaches New Milestone in Fight Against Malaria: 300 million ASAQ Treatments Delivered in Africa investment picks
New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 1, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY ) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that the first Phase 2 study with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), in Japanese patients met its primary endpoint.
Sign-up for Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study investment picks
Approval reinforces the safety profile of Adacel as an active booster immunization for the prevention of tetanus, diphtheria, and pertussis SWIFTWATER, Pa.
Sign-up for Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age investment picks
2014/4/29
PARIS , April 29, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first-quarter of 2014.
Sign-up for Sanofi Q1 2014 Results - Interview with CFO Jérôme Contamine investment picks
PARIS, April 7, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today that following constructive discussions with the U.S. Food and Drug Administration (FDA) the company plans to resubmit in the second quarter its supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
Sign-up for Sanofi: Genzyme to Resubmit Lemtrada Application for FDA Review investment picks
Slowing of Brain Atrophy and Reductions in New Multiple Sclrosis Lesions Sustained at Three Years in Patients Treated with Genzyme's Lemtrada TM - Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated with Lemtrada did not receive a third course of treatment in the first year of the extension - PARIS, April 30, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today new magnetic resonance imaging (MRI) data from the Lemtrada (alemtuzumab) clinical development program.
Sign-up for Sanofi: Slowing of Brain Atrophy and Reductions in New MS Lesions Sustained at Three Years in Patients Treated with Genzyme's Lemtrada investment picks
MIAMI , May 6, 2014 /PRNewswire/ -- Sanomedics International Holdings, Inc. (OTCQB: SIMH) ("Sanomedics"), a medical technology holding company that focuses on game-changing products, services and ideas, today announced that they continue to move forward with their aggressive growth strategy of acquiring existing businesses that generate revenue and anticipate will be accretive to earnings, as well as continue to foster the organic growth of the existing business.
Sign-up for Sanomedics continues to move forward with their strategic growth plans investment picks
2014/4/8
BOSTON , April 8, 2014 /PRNewswire/ -- Santander Bank, N.A. announced today the appointments of Jerry Plush as chief financial officer of Santander Holdings USA , Inc., the bank's U.S. holding company, and Maria Tedesco as managing director of retail banking for Santander Bank.
Sign-up for Santander Appoints Jerry Plush As CFO And Maria Tedesco As Head Of Retail Banking investment picks
2014/4/28
DALLAS , April 28, 2014 /PRNewswire/ -- Santander Consumer USA Holdings Inc. (NYSE: SC) ("SCUSA") will release first quarter financial results on Thursday, May 1, 2014 .
Sign-up for Santander Consumer USA Holdings Inc. Announces First Quarter 2014 Earnings Conference Call Information investment picks
BOSTON , April 14, 2014 /PRNewswire/ -- Santander Holdings USA , Inc. (SHUSA), parent company of Santander Bank , N.A., announced today that its Board of Directors declared a dividend on SHUSA's Preferred Stock.
Sign-up for Santander Holdings USA Declares Quarterly Dividend On Preferred Stock investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0941569001&sourceType=1 http://media3.marketwire.com/logos/20130109-santonia200.jpg CALGARY, ALBERTA --
Sign-up for Santonia Energy Inc. Announces Completion of Acquisition by Tourmaline Oil Corp. investment picks
ALPHARETTA, Ga., March 18, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced it has closed a private placement with institutional and select accredited investors raising total gross proceeds of $10.1 million.
Sign-up for SANUWAVE Closes $10.1M Private Placement Led by RA Capital Management investment picks
ALPHARETTA, Ga., May 12, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled "Methods and Devices for Cleaning and Sterilization with Shock Waves." The claims of the patent (patent number 8,685,317) relate to the use of shock waves to clean and sterilize fluids in containers and/or pipes.
Sign-up for SANUWAVE Receives U.S. Patent for Cleaning and Sterilization of Fluids and Food Liquids With Shock Waves investment picks
ALPHARETTA, Ga., May 20, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today received a patent issued by the U.S. Patent and Trademark Office entitled "Use of Pressure Waves for Stimulation, Proliferation, Differentiation and Post-Implantation Viability of Stem Cells." The claims of the patent (patent number 8,728,809) relate to the use of shock waves for stimulation of proliferation inside the body of donor stem cells.
Sign-up for SANUWAVE Receives U.S. Patent for Stem Cell Treatments Using Shock Wave Technology investment picks
2014/5/5
By Michael Hickins A key executive in the development of the analytic platform on which SAP AG has staked much of its future, has resigned for personal reasons, effective immediately, the company said.
Sign-up for SAP's Vishal Sikka resigns for personal reasons investment picks
2014/5/12
Record Quarterly Revenue of $36.6 Million, Up 16.3% Year-Over-Year HOLON, Israel , May 12, 2014 /PRNewswire/ -- Sapiens International Corporation , (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announced today its financial results for the first quarter ended March 31, 2014 .
Sign-up for Sapiens Reports Results for the First Quarter 2014 investment picks
2014/4/24
HOLON, Israel , April 24, 2014 /PRNewswire/ -- Sapiens International Corporation , (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, announced today that it will report its financial results for the first quarter ended March 31, 2014 on Monday, May 12, 2014 .
Sign-up for Sapiens to Announce First Quarter 2014 Financial Results on Monday, May 12, 2014 investment picks
Sapient (NASDAQ: SAPE) today announced that Gaston Legorburu, worldwide chief creative officer - SapientNitro, and Chris Davey, senior vice president and managing director, global customer engagement platform lead, will present at the 4th Annual Wells Fargo Tech Transformation Summit at the St.
Sign-up for Sapient to Present at Wells Fargo Tech Transformation Summit investment picks
2014/5/22
Carnival plc celebrates Princess Cruises' Inaugural Homeport China Program Offering 'Princess Class' Cruise Experience SANTA CLARITA, Calif.
Sign-up for Sapphire Princess Launches Cruise Season from Home Port of Shanghai investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0939603001&sourceType=1 http://www.ccnmatthews.com/logos2/saputo.gif MONTREAL, QUEBEC --
Sign-up for Saputo Completes the Acquisition of the Fluid Milk Activities of Scotsburn Co-Operative Services Limited investment picks
2014/4/16
DARIEN, Conn.
Sign-up for Sarah Amatuzio Joins Alcone as Vice President, Creative Director investment picks
World-Class Destination Resort in Rensselaer County Will Create 1,700 Permanent and 1,700 Construction Jobs, Grow the Local Economy While Keeping Taxes Down and NY Gaming Dollars in NY EAST GREENBUSH, N.Y., May 13, 2014 (GLOBE NEWSWIRE) -- Saratoga Casino and Raceway (SCR) and Churchill Downs Incorporated (Nasdaq:CHDN) (CDI) today announced they will partner in bidding for the Capital Region's commercial casino license to build a $300 million world class destination resort casino in the Town of East Greenbush.
Sign-up for Saratoga Casino and Raceway & Churchill Downs Incorporated Announce Historic Partnership on Game Changing Casino at East Greenbush investment picks
NEW YORK , May 14, 2014 /PRNewswire/ -- Saratoga Investment Corp.
Sign-up for Saratoga Investment Corp. to Report Fiscal Fourth Quarter and Year End 2014 Financial Results and Hold Conference Call investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference to Saratoga Investment Corp. to Report Fiscal Fourth Quarter and Year End 2014 Financial Results and Hold Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry